/
/
/

Beryl Drugs Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)23.94
Volume (₹)1,506.00
High (₹)23.94
Upper Circuit28.75
Low (₹)21.50
Lower Circuit19.17
Prev Close23.96
52W High (₹)27.60
Price23.23
52W Low (₹)15.92

Share Market Cap & Key Ratios Overview

M.Cap (₹)12.15 Cr
Div. Yield (%)0.00
PE Ratio19.47
Debt to Equity0.43
Price to Book1.13
Book Value18.70
EPS (TTM)1.23
Face Value10.00
ROE (%)6.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
BERLDRG-XNSE
LTP
1W Low
1W High
Market cap (₹)
1853.5+18 (0.98%)
1835.50
1890.40
4,44,597Cr
9610+243 (2.59%)
9305.95
9739.85
2,55,195Cr
4985+180.75 (3.76%)
4864.80
5010
1,87,712Cr
1202+49 (4.25%)
1152
1208.20
1,17,705Cr
1397.2+25.75 (1.88%)
1364
1420.50
1,13,423Cr
2001+45.75 (2.34%)
1964.50
2054.55
1,09,481Cr
2460+142 (6.13%)
2302.30
2511.80
1,02,229Cr
1202.8+31.7 (2.71%)
1186.20
1221.60
1,00,195Cr
1711.3-23.7 (-1.37%)
1690
1739.60
98,965Cr
2090-54.7 (-2.55%)
2077
2129.85
95,939Cr
23.23-0.46 (-1.94%)
21.50
24.25
12Cr

Key Highlights of Beryl Drugs Ltd Balance Sheet

Beryl Drugs Ltd balance sheet discloses shareholders' funds of ₹5.09Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.09Cr, and the reserves and surplus of the company is ₹4.41Cr.

The company has its non-current liabilities with total liabilities of ₹16.03Cr as of 2025-03-31.

The current liabilities are ₹4.38Cr as of 2025-03-31. At the same time, current assets are ₹9.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹6.01Cr, provided in the Beryl Drugs Ltd financial statements.